Part 1: Introduction.- Chapter 1. Introduction to Retinitis Pigmentosa.- Chapter 2. Treatments.- Chapter 3. Notes.-Part 2: Completed Clinical Trials.
- Chapter 4. United States.- Chapter 5. Brazil.- Chapter 6. Turkey.-Part 3: Active, Recruiting Clinical Trials.- Chapter 7.
United States.- Chapter 8. Latin America.- Chapter 9. Turkey.-Part 4: Not Yet Recruiting Clinical Trials.- Chapter 10. Indonesia.
-Part 5: Active, Not Recruiting.- Chapter 11. United States.- Chapter 12. France.-Part 6: Enrolling by Invitation.- Chapter 13. United States.
- Chapter 14. Indonesia.-Part 7: Gene Therapy Studies.- Chapter 15. United States/Europe.- Chapter 16. India.- Chapter 17.
Saudi Arabia.-Part 8: Active, Recruiting Gene Therapy Studies.- Chapter 18. United States.- Chapter 19. China.-Part 9: Active, Not Recruiting Gene Therapy Studies.- Chapter 20.
United States.- Chapter 21. Germany.- Chapter 22. Sweden.-Part 10: Enrolling by Invitation Gene Therapy Studies.- Chapter 23. Americas/Europe.
- Chapter 24. India.-Part 11: Optogenetics.- Chapter 25. Active Trials in United States.-Part 12: Other Treatments.- Chapter 26. Completed Trials in The Americas/Europe.
- Chapter 27. Completed Trials in China.- Chapter 28. Completed Trials in Italy.- Chapter 29. Completed Trials in Turkey.- Chapter 30. Active Trials in the United States.
- Chapter 31. Active Trials in Australia.- Chapter 32. Active Trials in China.- Chapter 33. Active, Not Recruiting Trials in the US/Europe.- Chapter 34. Not Yet Recruiting Trials in China.